Lung cancer is one of the most common malignancies worldwide and contributes to most
cancer‐related morbidity and mortality cases. During the past decades, the rapid …

Lung cancer has been the main cause of cancer mortality worldwide. Furthermore, lung
cancer rates of new cases per year evidenced a large incidence of this neoplasm in both …

Background Smoking at diagnosis is associated with worse survival in lung cancer but the
effects of quitting smoking on survival remain unclear. Methods In a UK multi-centre study …

Objective This study aimed to explore the efficacy and safety of combining epidermal growth
factor receptor tyrosine kinase inhibitors (EGFR-TKIs) with ZiLongJin Tablet (ZLJT) in …

Background. All YTH domain family members are m6A reader proteins accounting for the
methylation modulation involved in the process of tumorgenesis and tumor progression …

The discovery of epidermal growth factor receptor (EGFR) mutations has greatly changed
the clinical outlook for patients with advanced non-small cell lung cancer (NSCLC). Unlike …

Background Lung cancer is a very common cancer with poor prognosis and high mortality.
Circular RNAs (circRNAs) have been confirmed to be related to the occurrence of lung …

Recently, targeted therapy and immunotherapy have emerged as effective treatment options
for non-small cell lung cancer (NSCLC). This progress has been facilitated by the rapid …

Background The aberrant expression of the classical tumor suppressor gene p16 is a
frequent event in lung cancer mainly due to the hypermethylation of its 5'-cytosine …

In patients with advanced lung adenocarcinoma (LADC) harboring the echinoderm
microtubule-associated protein-like 4 (EML4)-anaplastic lymphoma kinase (ALK) …